Monday, February 13, 2012, 2PM - 4 PM, Sutardja Dai Hall, Room 250 (
map)
Dr. Bingham is a member of the Board and co-founder of InnoCentive, Inc. He
has been a strong advocate of open innovation and founded InnoCentive, Inc.,
along with other ventures that create the advantages of open and networked
organizational structures, including: YourEncore, Inc., Coalesix, Inc., Maaguzi,
Inc., Indigo Biosystems, Seriosity, Chorus and Collaborative Drug Discovery,
Inc.
He currently serves on the Board of Directors of Fast Track Systems, Inc.,
and Collaborative Drug Discovery, Inc.; the advisory boards of the Center for
Collective Intelligence (MIT), Phase Forward, Inc., YourEncore, Inc. and
Coalesix, Inc. and as a member of the board of trustees of the Bankinter
Foundation in Madrid.
He has lectured extensively at both national and international events and
serves as a Visiting Scholar at the National Center for Supercomputing
Application at the University of Illinois at Champaign-Urbana. He is also the
former chairman of the Board of Editors of the Research Technology Management
Journal. Dr. Bingham was the recipient of the Economist's Fourth Annual
Innovation Summit "Business Process Award" for InnoCentive. He was also named as
one of Project Management Institute's "Power 50" leaders in October 2005.
Dr. Bingham had over 25 years of experience with Eli Lilly and Company in
pharmaceutical research and development, research acquisitions and
collaborations, portfolio management and R&D strategic planning. Among
others, he held positions as Managing Director of the Mont-Saint-Guibert
Development Centre, executive director of project and portfolio management,
vice-president of sourcing innovation, vice-president of e.Lilly and
vice-president of R&D strategy. During his career he was instrumental in
creating and developing Eli Lilly's portfolio management process as well as
establishing the divisions of Research Acquisitions, the Office of Alliance
Management and e.Lilly, a unit for business innovation.
In April 2011, Alph and CEO of InnoCentive Dwayne
Spradlin co-authored the groundbreaking book,
The Open Innovation Marketplace, published by FT Press. Dr. Bingham received a B.S. in
chemistry from Brigham Young University and a Ph.D. in organic chemistry from
Stanford University.
Read Alph's blog posts and be sure to see him at the upcoming Topics In Open Innovation Speaker Series.
The Topics In Open
Innovation Speaker Series is a weekly series intended to provide both academic
and managerial perspectives on open innovation and related subjects. Admission
to the speaker series is free to students, alumni, faculty, and the University
of California community.